Osteoporosis
Conditions
Interventions
Zoledronic acid treatment group:Nil
None zoledronic acid treatment group:Nil
Sponsors
Leshan People's Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Inpatients with zoledronic acid for osteoporosis and those without zoledronic acid in the endocrinology department; 2. Men or women aged 18 to 85 years; 3. Voluntarily chose to participate in this clinical study.
Exclusion criteria
Exclusion criteria: 1. Patients with type 1 diabetes, type 2 diabetes, gestational diabetes, diabetes of unknown type, and special type of diabetes; 2. GFR sustained < 45mL/min/1.73^2, patients with severe renal impairment, end-stage renal disease or dialysis; 3. Women who are pregnant or breastfeeding, have had malignant tumor within 2 years and acute cerebrovascular accident within half a year; 4. Patients with abnormal thyroid function, hyperthyroidism, and hypothyroidism;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood lipids; | — |
Countries
China
Contacts
Public ContactLuo Wei
Leshan People's Hospital
Outcome results
None listed